Organelle-specific targeting of polymersomes into the cell nucleus.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
11 02 2020
Historique:
pubmed: 29 1 2020
medline: 28 5 2020
entrez: 29 1 2020
Statut: ppublish

Résumé

Organelle-specific nanocarriers (NCs) are highly sought after for delivering therapeutic agents into the cell nucleus. This necessitates nucleocytoplasmic transport (NCT) to bypass nuclear pore complexes (NPCs). However, little is known as to how comparably large NCs infiltrate this vital intracellular barrier to enter the nuclear interior. Here, we developed nuclear localization signal (NLS)-conjugated polymersome nanocarriers (NLS-NCs) and studied the NCT mechanism underlying their selective nuclear uptake. Detailed chemical, biophysical, and cellular analyses show that karyopherin receptors are required to authenticate, bind, and escort NLS-NCs through NPCs while Ran guanosine triphosphate (RanGTP) promotes their release from NPCs into the nuclear interior. Ultrastructural analysis by regressive staining transmission electron microscopy further resolves the NLS-NCs on transit in NPCs and inside the nucleus. By elucidating their ability to utilize NCT, these findings demonstrate the efficacy of polymersomes to deliver encapsulated payloads directly into cell nuclei.

Identifiants

pubmed: 31988132
pii: 1916395117
doi: 10.1073/pnas.1916395117
pmc: PMC7022206
doi:

Substances chimiques

Biocompatible Materials 0
Karyopherins 0
Nuclear Localization Signals 0
Polymers 0
Guanosine Triphosphate 86-01-1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2770-2778

Informations de copyright

Copyright © 2020 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Eur J Pharm Sci. 2010 Jan 31;39(1-3):152-63
pubmed: 19961929
Nano Lett. 2016 Nov 9;16(11):7128-7136
pubmed: 27726407
Acc Chem Res. 2011 Oct 18;44(10):1039-49
pubmed: 21608994
Nat Commun. 2018 Mar 19;9(1):1127
pubmed: 29555899
Science. 2007 Oct 26;318(5850):640-3
pubmed: 17916694
Mol Pharm. 2015 Dec 7;12(12):4277-89
pubmed: 26465978
EMBO J. 1996 Oct 15;15(20):5584-94
pubmed: 8896452
Nat Rev Drug Discov. 2005 Apr;4(4):307-20
pubmed: 15789122
J Biol Chem. 2001 Sep 7;276(36):34189-98
pubmed: 11448961
Adv Drug Deliv Rev. 2013 Jan;65(1):36-48
pubmed: 23036225
Nat Rev Mol Cell Biol. 2003 Oct;4(10):757-66
pubmed: 14570049
J Cell Biol. 2017 Nov 6;216(11):3609-3624
pubmed: 28864541
J Struct Biol. 2012 Jan;177(1):90-8
pubmed: 22100338
Nat Protoc. 2007;2(11):2842-56
pubmed: 18007619
Nature. 1997 Sep 18;389(6648):239-42
pubmed: 9305836
Chem Asian J. 2008 Mar 7;3(3):548-552
pubmed: 18080259
Mol Cell Biol. 1999 Feb;19(2):1210-7
pubmed: 9891055
Nat Nanotechnol. 2016 Aug;11(8):719-23
pubmed: 27136131
Nat Rev Mol Cell Biol. 2010 Jul;11(7):490-501
pubmed: 20571586
Mol Biol Cell. 2002 Feb;13(2):425-34
pubmed: 11854401
Nat Rev Genet. 2005 Apr;6(4):299-310
pubmed: 15761468
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9849-54
pubmed: 12909718
Biomacromolecules. 2002 May-Jun;3(3):565-78
pubmed: 12005530
Cell. 1991 Feb 8;64(3):615-23
pubmed: 1991323
Langmuir. 2004 Feb 3;20(3):540-3
pubmed: 15773070
J Cell Biol. 2016 Oct 10;215(1):57-76
pubmed: 27697925
Science. 1999 May 14;284(5417):1143-6
pubmed: 10325219
Adv Healthc Mater. 2018 Apr;7(8):e1701276
pubmed: 29334183
Cell. 2017 Nov 2;171(4):904-917.e19
pubmed: 29033133
J Biol Chem. 2000 Feb 25;275(8):5874-9
pubmed: 10681579
J Control Release. 2016 May 10;229:140-153
pubmed: 26995759
Nat Rev Genet. 2014 Aug;15(8):541-55
pubmed: 25022906
Molecules. 2014 Jun 23;19(6):8589-609
pubmed: 24959684
J Ultrastruct Res. 1969 May;27(3):250-65
pubmed: 4181256
EMBO J. 2013 Dec 11;32(24):3220-30
pubmed: 24213245
Annu Rev Cell Dev Biol. 1999;15:607-60
pubmed: 10611974
Biophys J. 2017 Sep 19;113(6):1311-1320
pubmed: 28697897
J Am Chem Soc. 2012 Apr 4;134(13):5722-5
pubmed: 22420312
J Mol Biol. 2016 May 22;428(10 Pt A):2060-90
pubmed: 26523678
Chem Rev. 2009 Feb;109(2):259-302
pubmed: 19053809
Mol Biol Cell. 2015 Apr 1;26(7):1386-94
pubmed: 25631821
Nat Nanotechnol. 2014 Jul;9(7):525-30
pubmed: 24929341
Science. 2004 Nov 19;306(5700):1387-90
pubmed: 15514115
Chem Soc Rev. 2016 Jan 21;45(2):377-411
pubmed: 26563574
Biophys J. 2014 Apr 15;106(8):1751-62
pubmed: 24739174
J Control Release. 2005 Feb 2;102(2):475-88
pubmed: 15653165
J Control Release. 2009 Aug 4;137(3):246-54
pubmed: 19371766
Nature. 1984 Sep 6-11;311(5981):33-8
pubmed: 6088992
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):16911-6
pubmed: 23043112
Nat Rev Mol Cell Biol. 2007 Mar;8(3):195-208
pubmed: 17287812
Mol Pharm. 2017 Jun 5;14(6):1916-1928
pubmed: 28493710

Auteurs

Christina Zelmer (C)

Biozentrum and the Swiss Nanoscience Institute, University of Basel, CH-4056 Basel, Switzerland.
Department of Chemistry, University of Basel, CH-4002 Basel, Switzerland.

Ludovit P Zweifel (LP)

Biozentrum and the Swiss Nanoscience Institute, University of Basel, CH-4056 Basel, Switzerland.

Larisa E Kapinos (LE)

Biozentrum and the Swiss Nanoscience Institute, University of Basel, CH-4056 Basel, Switzerland.

Ioana Craciun (I)

Department of Chemistry, University of Basel, CH-4002 Basel, Switzerland.

Zekiye P Güven (ZP)

Institute of Materials, Ecole Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.

Cornelia G Palivan (CG)

Department of Chemistry, University of Basel, CH-4002 Basel, Switzerland; cornelia.palivan@unibas.ch roderick.lim@unibas.ch.

Roderick Y H Lim (RYH)

Biozentrum and the Swiss Nanoscience Institute, University of Basel, CH-4056 Basel, Switzerland; cornelia.palivan@unibas.ch roderick.lim@unibas.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH